ストックスクリーナーアプリを入手
3.04
1.00%
0.04
前日終値:
$3.00
開ける：
$3.35
24時間の取引高:
407.37K
Relative Volume:
0.94
時価総額：
$110.46M
収益：
-
当期純損益:
$-42.94M
株価収益率:
-1.8765
EPS:
-1.62
ネットキャッシュフロー:
$-33.64M
1週間 パフォーマンス:
+0.66%
1か月 パフォーマンス:
-6.77%
6か月 パフォーマンス:
-38.16%
1年 パフォーマンス:
-43.26%
1日の値動き範囲:
$3.02
$3.35
1週間の範囲:
$2.93
$3.35
52週間の値動き範囲:
$2.53
$6.85
Pds Biotechnology Corporation Stock (PDSB) Company Profile
名前
Pds Biotechnology Corporation
セクター
電話
800-208-3343
住所
303A COLLEGE ROAD EAST, PRINCETON
Pds Biotechnology Corporation Stock (PDSB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-11-01 | 開始されました | B. Riley Securities | Buy |
| 2021-06-28 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-11-10 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-05-27 | 開始されました | Alliance Global Partners | Buy |
| 2020-03-09 | 開始されました | Noble Capital Markets | Outperform |
| 2019-10-24 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Pds Biotechnology Corporation (PDSB) 最新ニュース
PDS: Updated Results, VERSATILE-002 Phase 2 Trial - ShareCast
PDS Biotech Advances with Promising Versamune® HPV Trial Results - TipRanks
PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024 - StockTitan
PDS Biotechnology Co. (NASDAQ:PDSB) Receives $14.25 Consensus Target Price from Analysts - MarketBeat
PDS Biotechnology Co. (NASDAQ:PDSB) Given Average Recommendation of “Buy” by Brokerages - Defense World
Aneurysmal Subarachnoid Hemorrhage Drugs Market 95115.59mn Size, Spotlight on Future Potentials (2024-2034) - Talented India
PDS Biotech to Present Updated VERSATILE-002 Data at ESMO Congress 2024 - StockTitan
PDS Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Cervical Cancer Clinical Trials 2024: FDA Approvals, Pipeline, - openPR
A History of Outperforming Analyst Forecasts and Beating the Odds: PDS Biotechnology Corporation (PDSB) - SETE News
Comparing Moolec Science (NASDAQ:MLEC) & Ross Acquisition Corp II (NYSE:ROSS) - Defense World
Snap-on Incorporated (NYSE:SNA) CFO Aldo John Pagliari Sells 4,473 Shares of Stock - Defense World
Louisiana-Pacific Co. (NYSE:LPX) CEO William Bradley Southern Sells 32,600 Shares of Stock - Defense World
Samsara Inc. (NYSE:IOT) Insider John Bicket Sells 78,128 Shares of Stock - Defense World
PDS Biotechnology (NASDAQ:PDSB) Upgraded to "Strong-Buy" by Alliance Global Partners - MarketBeat
PDS Biotechnology (NASDAQ:PDSB) Given New $7.00 Price Target at Alliance Global Partners - Defense World
PDS Biotechnology (NASDAQ:PDSB) Price Target Raised to $7.00 - MarketBeat
PDS Biotechnology Co. (NASDAQ:PDSB) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Western Wealth Management LLC Purchases 1,800 Shares of Ares Capital Co. (NASDAQ:ARCC) - Defense World
Recurrent or Metastatic Head and Neck Cancer Pipeline Analysis 2024: Clinical Trials, FDA, EMA, PMDA Approvals - openPR
PDS Biotechnology Co. Forecasted to Earn FY2024 Earnings of ($1.17) Per Share (NASDAQ:PDSB) - MarketBeat
Aixtron Se (OTCMKTS:AIXXF) Sees Significant Decrease in Short Interest - Defense World
Vanguard Group Inc. Has $6.23 Million Stock Position in AstroNova, Inc. (NASDAQ:ALOT) - Defense World
Vanguard Group Inc. Grows Stock Position in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World
PDS Biotechnology Co. Forecasted to Post Q3 2024 Earnings of ($0.28) Per Share (NASDAQ:PDSB) - MarketBeat
Noble Financial Weighs in on PDS Biotechnology Co.’s Q3 2024 Earnings (NASDAQ:PDSB) - Defense World
PDS Biotechnology (NASDAQ:PDSB) Posts Earnings Results - Defense World
PDS Biotechnology updates market on new equity sales agreement By Investing.com - Investing.com Australia
PDS Biotechnology (NASDAQ:PDSB) Announces Earnings Results - MarketBeat
PDS Biotechnology updates market on new equity sales agreement - Investing.com India
PDS Biotechnology: Q2 Earnings Snapshot - Darien Times
NetScientific's PDS Biotech prepares phase 3 trial for VERSATILE-003 - Proactive Investors USA
NetScientific's PDS Biotech prepares phase 3 trial for VERSATILE-003 - Proactive Investors UK
PDS Biotechnology: Q2 Earnings Snapshot - New Haven Register
PDS Biotechnology: Q2 Earnings Snapshot - San Antonio Express-News
PDS Biotechnology updates market on new equity sales agreement - Investing.com
PDS Biotechnology: Q2 Earnings Snapshot - Houston Chronicle
PDS Biotechnology updates market on new equity sales agreement By Investing.com - Investing.com UK
PDS Biotechnology Enhances and Modulates Stock Sales Agreement - TipRanks
PDS Biotechnology: Q2 Earnings Snapshot - San Francisco Chronicle
PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results - BioSpace
PDS Biotechnology: Q2 Earnings Snapshot - Press of Atlantic City
PDS Biotech: Business Update and Q2 2024 Results - ShareCast
PDS Biotechnology: Q2 Earnings Snapshot - CTPost
PDS Biotechnology: Q2 Earnings Snapshot - Greenwich Time
PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results - wallstreet:online
PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results - StockTitan
PDSBPDS Biotechnology Corporation Latest Stock News & Market Updates - StockTitan
PDS Biotechnology (PDSB) Set to Announce Earnings on Tuesday - MarketBeat
PDS Biotechnology (PDSB) Set to Announce Quarterly Earnings on Tuesday - Defense World
PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting - StockTitan
Pds Biotechnology Corporation (PDSB) 財務データ
収益
当期純利益
現金流量
EPS
1.28%
1.94%
大文字化:
|
ボリューム (24 時間):